Abstract-Due to recent advances in microfluidics technology, digital microfluidic biochips and their associated computeraided-design problems have gained much attention, most of which has been devoted to direct-addressing biochips. In this paper, we solve the droplet routing problem under the more scalable cross-referencing biochip paradigm. We propose the first droplet routing algorithm that directly solves the problem of routing. We first present an optimal basic integer-linear-programming (ILP) formulation. Due to its complexity, we also propose a progressive-ILP scheme to determine the locations of droplets at each time step. Simulation results demonstrate the efficiency and effectiveness of our algorithm.
I. INTRODUCTION
R ECENTLY, there have been many significant advances in microfluidic technologies [2] . Microfluidic biochips show numerous advantages over conventional assay methods, including portability, sample/reagent volume reduction, and faster analysis, and offer a platform for developing clinical and diagnostic applications, such as infant health care and point-of-care disease diagnostics. Other promising applications include environmental toxin monitoring and automated and parallel drug discovery, and this breadth of applicability implies that microfluidic biochips are increasingly used in laboratory procedures in molecular biology.
First-generation biochips are based on manipulating continuous liquid flows using external pressure sources (e.g., micropumps) and microchannels. Although they have been successfully applied to many biological applications, their lack of reconfigurability makes them unsuitable for large-scale and scalable systems. Second-generation biochips are based on digitalizing continuous liquid flow into discrete liquid particles, called droplets [3] . Each droplet can be independently controlled by the electrohydrodynamic forces generated by electrodes. In this way, droplet movement can be controlled by a system clock. Due to this parallel with digital electronic systems, second-generation biochips are referred to as "digital microfluidic biochips."
Typically, a digital microfluidic biochip has a 2-D microfluidic array, which consists of a set of electrodes. Droplets are routed through this array, and various fundamental operations, such as droplet merging, droplet splitting, and droplet transportation, are performed on them during this process. In the simplest and most common droplet control scheme, each electrode is directly addressed and controlled by a dedicated control pin, which allows each electrode to be individually activated. In this paper, we refer to these types of digital microfluidic biochips as direct-addressing biochips. While this architecture provides a high flexibility for droplet movement, it suffers from the major drawback that the number of control pins rapidly increases as the system complexity (i.e., the size of the array) increases. The large number of control pins affects product cost, and the control-wire routing problems complicate the design process, and therefore, this architecture is only applicable to small-scale biochips (fewer than 10 × 10 electrodes) [4] .
To overcome these limitations, recently, a new digital microfluidic-biochip architecture has been proposed [5] . This architecture uses a row/column-addressing scheme, where all electrodes in one row (or column) are connected to a single control pin. Therefore, the number of control pins is greatly reduced: This number is now proportional to the perimeter of the chip rather than the area of the chip. We refer to this type of biochip architecture as the cross-referencing biochip architecture. However, this also introduces a new set of limitations. Since an electrode can potentially control the movement of all droplets in a row/column at the same time, this incurs higher droplet-movement complexity than that for direct-addressing biochips. Moreover, the manipulation of more than two droplets causes electrode interference among droplets, which prevents multiple droplets from moving at the same time. This limitation is a critical challenge in designing a low-cost cross-referencing biochip for high-performance applications, such as large-scale protein analysis.
In this paper, we tackle the problem of droplet routing in cross-referencing biochips. The main challenge of this routing problem is to ensure the correctness of droplet movement; the fluidic property which avoids unexpected mixing among droplets must be satisfied, and electrode-interference patterns 0278 -0070/$26.00 © 2009 IEEE that prevent multiple droplets from moving at the same time must be avoided. The goal of droplet routing is to minimize the maximum droplet-transportation time and has several motivations. First, this minimization is critical to real-time applications, such as monitoring environmental toxins. Second, the minimized droplet-transportation time leads to shorter time that a sample spent on a biochip, which is desirable to maintain the bioassay execution integrity.
A. Related Work
Droplet routing is a critical step in biochip design automation. Previous routing approaches mainly focus on direct-addressing biochips [6] - [10] . Recently, the problem of manipulating droplets on a cross-referencing biochip has attracted some attention, but to our knowledge, all existing methods begin with a direct-addressing routing result and transform it to a cross-referencing routing result, cycle-by-cycle. Griffith et al. [8] proposed a graph-coloring-based method that is applied to each successive cycle of the direct-addressing solution. Each node in an undirected graph represents a droplet, and two nodes are connected by an edge if these two droplets cannot move at the same time. Therefore, the minimum time to move all droplets is equivalent to the minimum number of colors required to color this undirected graph. Xu et al. [11] proposed a clique-partitioning-based method that is also sequentially applied to the direct-addressing solution. Each clique is a set of droplets whose destination cells, i.e., the cell to which the droplets are supposed to move, are in the same row or column. The number of cliques is the maximum time to move all droplets. Since clique partitioning is NP-hard, they proposed an efficient heuristic approach to solve this problem. However, droplets with different destination cells can move at the same time. Therefore, their algorithm may potentially increase droplet-transportation time. Any algorithm that uses the direct-addressing solution as a starting point is limited by that solution, and to the best of our knowledge, there is no existing routing algorithm that is directly targeted to crossreferencing biochips.
B. Our Contribution
In this paper, we propose an integer-linear-programming (ILP)-based droplet routing algorithm for cross-referencing biochips. We derive the basic ILP formulation to simultaneously perform droplet routing and assign voltages to the cross-referencing electrodes, while minimizing the maximum droplet-transportation time. Moreover, we also model multipin nets in our ILP formulation for practical bioassays, where multiple droplets are merged during their transportation. To overcome the computational cost of the ILP, we also propose a progressive-ILP routing scheme, which is used to find the minimum-cost droplet locations at each time step using an ILP. Unlike the progressive-ILP scheme proposed in [12] , which divides the original problem spatially, our algorithm divides the original routing problem temporally. In this way, the original problem is reduced to a manageable size, and we can practically apply an ILP-based method to find a good solution within reasonable CPU time. The major contributions of this paper include the following. 1) We propose the first routing algorithm that directly solves the routing problem in cross-referencing biochips. In contrast with previous works that start with an initial directaddressing routing solution, our algorithm has higher flexibility and can obtain better solutions for droplet routing on cross-referencing biochips. 2) To tackle the complexity of the basic ILP formulation, we propose the progressive-ILP routing scheme. This scheme iteratively determines the locations of droplets at each time step by ILP formulation and, therefore, can obtain a high-quality solution within reasonable CPU times. 3) Unlike previous works that only move a subset of droplets at each time (for example, the algorithm proposed in [11] only moves droplets whose destination cells are in the same row/column), our algorithm maximizes the number of droplets that can simultaneously move at the same time, even if the destination cells are not in the same row/column. Therefore, our algorithm can obtain a routing solution with lower droplet-transportation time. This minimization is particularly important for crossreferencing biochips due to the electrode-interference problem. Simulation results demonstrate the efficiency of our progressive routing scheme as compared with the basic ILP formulation. The basic ILP formulation requires more than five days while the progressive-ILP routing scheme requires no more than about 15 s for one bioassay. Simulation results also demonstrate the effectiveness of our algorithm as compared with previous work. For example, for the protein assay, our algorithm obtains 59.61% smaller maximum droplet-transportation time than the network-based method proposed in [10] plus the clique-partitioning-based algorithm proposed in [11] .
The remainder of this paper is organized as follows. Section II details routing on cross-referencing biochips and formulates the droplet routing problem. Next, Section III presents the basic ILP formulation for droplet routing problem and the complexity analysis. Section IV details the progressive-ILP routing scheme, while Section V shows the simulation results. Finally, concluding remarks are provided in Section VI.
II. ROUTING ON CROSS-REFERENCING BIOCHIPS
In this section, we first show the architecture of crossreferencing biochips. Next, we detail the unique electrode interference that could result in incorrect droplet movement and the fluidic constraints that avoid this and guarantee correct droplet movement. Finally, we present the problem formulation of the droplet routing problem. Fig. 1 shows the top view of a cross-referencing biochip. A droplet is sandwiched between two plates. A set of electrodes spans a full row in the X-dimension and a full column in the Y -dimension and is assigned either a driving or reference voltage. Two sets of electrodes are orthogonally placed, one set each on the top and bottom plates, as shown in Fig. 1 , and each electrode can be set to either a high or a low voltage level. A grid point is "addressed" if there is a potential difference between the upper and lower electrodes, i.e., one is high while the other is low. This causes a droplet at a neighboring grid point to move into this location.
A. Cross-Referencing Biochips
The advantage of cross-referencing biochips is that we require onlyŴ +Ĥ control wires for droplet movement, instead of theŴĤ control wires required for direct-addressed biochips, whereŴ (Ĥ) is the width (height) of a biochip, measured in terms of the number of electrodes in each dimension. Therefore, these biochips incur reduced package and fabrication costs.
B. Electrode Constraint
The improvement in packaging and fabrication costs, described earlier, comes at the cost of reduced flexibility for droplet movement, as compared to direct-addressing biochips. When moving multiple droplets simultaneously, we must set potential levels on multiple rows/columns as driving electrodes. However, since each set of electrodes in the X(Y )-direction spans the entire row (column), setting electrode-voltage values to move a set of droplets could imply that some droplets may be inadvertently and incorrectly moved. We show this idea in Fig. 2 , where our goal is to move three droplets at the same time, to neighboring locations. The picture shows the set of voltage assignments to the electrodes to achieve this goal: These destinations of the droplets are selected by activating the corresponding rows and columns and by setting one of the lines to high and the other to low. However, due to the grid structure, several other locations are also accidentally activated. If either of these is adjacent to a droplet, it will cause an unwanted effect. For example, in this scheme, droplet 2 is now attracted to the locations just above and just below it and is likely to split into two. This scenario is referred to as electrode interference, and it must be avoided during droplet transportation. The restriction that avoids electrode interference is referred to as an electrode constraint. Note that not every extra activated cell causes incorrect droplet movement: For example, the top-right activated cell has no effect on droplet movement, since it has no neighboring droplets. Only the extra activated cells that are around a droplet and its destination cell may cause incorrect droplet movement.
The electrode constraint imposes serious restrictions on the movement of multiple droplets. When more than two droplets are moved, we may have to stall some droplets to satisfy the electrode constraint, which will result in longer droplettransportation times. For example, in Fig. 2 , we can stall droplet 3 and move the other two, and this will avoid electrode interference. The manner in which electrode constraints are handled is a critical routing consideration in cross-referencing biochips and is important in minimizing the droplet-transportation time.
We now show how the electrode constraint can be modeled. Suppose that a droplet d moves from cell (x, y) to cell (x + 1, y) at time t + 1, as shown in Fig. 3 . Then, the cell (x, y), as well as the ten cells that surround (x, y) ∪ (x + 1, y), as shown in Fig. 3 , must be deactivated. Otherwise, d is attracted by two electrohydrodynamic forces, so d may move incorrectly or be split into two smaller droplets. Note that in the case that d stays at its original location, cell (x, y) does not necessarily have to be activated, and all the neighboring cells of (x, y) must be deactivated, as demonstrated in [13] .
C. Fluidic Constraint
Besides the electrode constraint, we must also satisfy the static and dynamic fluidic constraints for correct droplet movement [9] , [10] . The static fluidic constraint states that the minimum spacing between two droplets must be one cell, while the dynamic fluidic constraint is related to two moving droplets. To satisfy the dynamic fluidic constraint, if a droplet d moves to cell (x, y) at time t + 1, then there must be no other droplet d which can move from one of the eight neighboring cells of (x, y) to another cell at time t + 1. Fig. 4 shows the dynamic fluidic constraint. In the figure, cell (x, y) must be activated for droplet d, since a droplet moves to a cell only if that cell is activated. However, the electrode constraint dictates that cell (x, y) cannot be activated; otherwise, droplet d can move incorrectly. In other words, enforcing the electrode constraint for all drops ensures that the dynamic fluidic constraint is automatically satisfied (however, it is easy to show that the reverse is not true). As a result, our electrode constraints subsume the dynamic fluidic constraints, and we do not have to explicitly specify the latter.
D. Problem Formulation
In this paper, we focus on droplet-transportation problem. As stated in [9] and [10] , the droplet-transportation problem can be represented in a 3-D space, where the third dimension corresponds to time. At each time step, the problem reduces to working with the droplet-movement problem in a 2-D plane. We focus the problem formulation on one 2-D plane, noting that similar constraints may be added for every other 2-D plane. When routing droplets on one 2-D plane, we consider the modules (and the surrounding segregation cells) that are active as obstacles. Besides, for practical bioassays, we must be able to handle three-pin nets to represent the fact that two droplets may have to be merged during their transportation for efficient mix operations [9] , [14] . Therefore, the droplet routing problem for each 2-D plane can be formulated as follows:
Input 
III. ILP FORMULATION FOR DROPLET ROUTING
In this section, we present the basic ILP formulation for one 2-D plane. We show how the ILP optimizes droplet routing and scheduling and voltage assignment on the electrodes, with the consideration of three-pin nets, and then, we analyze the computational complexity of the formulation and propose a practical approach for problem size reduction.
A. Basic ILP Formulation
Based on the modeling of electrode constraint shown in Fig. 3 , the electrode constraint can be modeled by the following three rules.
1) If a droplet is at cell (x, y) at time t, then the four diagonally adjacent cells cannot be activated at time t + 1. 2) If a droplet moves to cell (x , y ) at time t + 1, then the eight neighboring cells of (x , y ) cannot be activated at t + 1. 3) If a droplet is at cell (x, y) at time t, at most one cell can be activated among cells (x, y) and its four adjacent cells. Note that both rules 1) and 2) state that the cells diagonally adjacent to cell (x, y) cannot be activated at time t + 1. This redundancy reduces the size of the basic ILP formulation; otherwise, extra variables are required to represent the moving direction of each variable p i j (x, y, t) and extra constraints to determine the values of these extra variables.
In the following sections, we introduce the objective function and constraints of the basic ILP formulation. The notations used in the proposed ILP formulation are shown in Table I .
1) Objective function:
The goal is to minimize the latest time a droplet reaches its sink. Therefore, the objective function is defined by the following:
2) Constraints: There are totally eight constraints in the basic ILP formulation.
Objective-function computation: If a droplet reaches its sink at time t + 1, then the time when it reaches its sink can be computed as t + 1 times the difference of the two variables p . Therefore, the objective function can be computed by the following constraint:
Source and sink requirements: We assume that at time zero, all droplets are at their source locations. All droplets must reach their sinks. Once a droplet reaches its sink, it remains there. Therefore, the earlier requirements can be represented by the following constraints:
Exclusivity constraint: The exclusivity constraint states that, at each time step, a droplet only has one location and can be represented by the following constraint:
(6) Static fluidic constraint: To satisfy the static fluidic constraint, the minimum spacing between two droplets must be one cell. In other words, there are no other droplets in the 3 × 3 region centered by a droplet. The static fluidic constraint can be modeled by the following constraint:
Voltage assignment and cell activation: Each row/column can be assigned one voltage (high or low), or left floating, at any time. A cell is activated if and only if it is in the intersection of a row with high (low) voltage and a column with low (high) voltage. Therefore, this constraint can be modeled by the following constraints:
We use the following five equations and two additional variables to linearize constraint (10):
where b x,y 2 (t) cannot be one at the same time, since a row/column can be assigned to only one voltage at a time.
Droplet-movement constraint: A droplet can only move to an adjacent cell, which must be activated before the movement occurs. On the other hand, if a droplet is to stay at its original location, the corresponding cell may or may not be activated. Therefore, the droplet-movement constraint can be represented by the following constraints:
Note that activating a cell does not imply that a droplet will move to this cell, as shown in the case of the top-right extra activated cell in Fig. 2 . Therefore, constraint (17) 
Three-pin nets: We use the following three constraints to handle the three-pin nets:
Constraint (21) is used to determine whether two droplets are merged, i.e., in the same physical location. Constraint (22) is used to guarantee that two droplets must be merged during their transportation by restricting and that their physical location must be the same for at least one time step. Constraint (23) states that these two droplets must be merged before reaching their sink. We use the following five equations and two additional variables to linearize constraint (21):
is less than or equal to zero. Therefore, these two variables cannot be one at the same time. Note that once these two droplets are merged, they will always move together by the droplet-movement constraint. Therefore, these two droplets are not splitting once they are merged.
B. Complexity Analysis
It is easy to verify that the number of variables that represent the droplet location dominates the total number of variables. The number of variables that represents the locations of droplets at each time is O(|D|ŴĤT ), and therefore, this is the order of the total number of variables in the basic ILP formulation.
It can be verified that the fluidic constraint (7) introduces the maximum number of constraints, since it models the relationship between every pair of droplets. This amounts to a total of O(|D| 2ŴĤ T ) constraints, and this is the order of the number of constraints in the basic ILP formulation.
Based on the earlier discussion, we present the following observation:
Given a set of nets N of one 2-D plane, a biochip of the width (height)Ŵ (Ĥ), and the maximum droplet-transportation time T , the number of variables and constraints of the basic ILP formulation for one 2-D plane are O(|D|ŴĤT ) and O(|D|
2ŴĤ T ), respectively.
C. Implementational Issues
We now present techniques for practically reducing the number of variables/constraints, without affecting the optimality of the basic ILP formulation. We use the concept of the idle interval presented in [10] 
. With this approach, we can also eliminate unnecessary constraints. For example, for every variable p 
IV. PROGRESSIVE-ILP ROUTING SCHEME
Although the basic ILP formulation presented in the previous section can solve the droplet-transportation problem, it may incur high runtimes. Hence, it may be hard to directly apply the basic ILP formulation to practical bioassays. In this section, we present a progressive-ILP routing scheme to solve the droplet-transportation problem. The main idea is to divide the original problem into a set of subproblems corresponding to each time step. The goal of each subproblem is to find mincost locations of the droplets at next time step by ILP. In the following sections, we first overview the progressive-ILP routing scheme and, then, present the ILP formulation. Next, we present approaches for handling three-pin nets and determining the droplet-movement cost. Finally, we present a complexity analysis and some implementation details.
A. Progressive Routing Algorithm Overview
Fig . 5 shows the overview of the progressive routing scheme. The essential intuition is that this scheme finds the optimal movement of droplets progressively, one time step at a time. We first set T l as the maximum Manhattan distance of all droplets from their sources and sinks. Until all droplets reach their sinks, we first calculate the droplet-movement cost, and then, we construct the progressive-ILP formulation and solve it by an ILP solver. Finally, if it is found that some droplets cannot be routed within time T l , then T l is increased by α times the maximum Manhattan distance, where α is a user-specified constant and is set to be 0.2.
B. Progressive-ILP Formulation
The key idea of the progressive-ILP method is to reduce the problem to a manageable size by solving a series of subproblems. The problem size can be further reduced by observing that the electrode and static fluidic constraints and droplet movement have only local effects when the locations of the droplets are known. To satisfy the static fluidic constraint, we observe that, after a droplet moves, two droplets are adjacent to each other only if a cell with more than one droplet nearby is activated. Therefore, we do not activate this cell in the progressive-ILP formulation. Finally, each droplet d i j can either move to one of its four adjacent cells or stay at its original location. That is, the possible position of a droplet can be represented as a "cross" shown in Fig. 6 . Therefore, variables a x,y t+1 are required to represent the cell (x i,j t , y i,j t ) and its four adjacent cells. Other cells either must be deactivated (within the 5 × 5 region) or have no effect on droplet movement (outside the 5 × 5 region). In this way, unnecessary variables can be eliminated. We now present the progressive-ILP formulation in the following sections. The notations used in the progressive-ILP formulation are also listed in Table I .
1) Objective function:
The goal of the progressive-ILP formulation is to find the min-cost droplet movement. Therefore, the objective function can be represented as the following: 2) Constraints: There are five constraints in the progressive-ILP formulation.
Droplet-movement constraint: A droplet can move to one of its four adjacent cells if and only if this cell is activated. Therefore, this constraint can be expressed by the following constraint:
The above constraint can easily be linearized by the following:
Note that since only the four adjacent cells are associated with cell-activation variables, the cell activation and the droplet movement must be modeled as an "if-and-only-if" relation, unlike the "if" relation in the basic ILP formulation. Moreover, a cell stays at its original location if and only if all its four adjacent cells are deactivated. Therefore, we use the following constraints to represent this situation:
(34)
Electrode constraint: Rule 1), which states that the diagonal cells cannot be activated, can be represented as
The following two constraints, similar to constraint (19), are used for rule 2): 
Similarly, the same method can be used to linearize constraint (38). Finally, for rule 3), we impose the following constraint:
Static fluidic constraint: Since the locations of the droplets are known, we model the static fluidic constraint in a simpler way. The fluidic constraint is violated only if a cell with more than one droplet nearby is activated. Therefore, instead of using constraint (7), we represent the fluidic constraint as follows:
if more than one droplet is around cell (x, y)
Sink requirement: Once a droplet reaches its sink, it must stay there. The sink requirement can be modeled by the following constraint:
which means that if d i j reaches its sink at time t, then it must stay there at time t + 1.
Voltage assignment and cell activation: This constraint is the same as that in the basic ILP formulation.
C. Droplet-Movement Cost
A key issue in the progressive-ILP routing scheme is the determination of the droplet-movement cost. Since the goal is to minimize the maximum droplet-transportation time, the objective is to move a droplet toward its sink at each time step. Furthermore, congestion must be avoided among droplets; otherwise, either a detour occurs or some droplets stall for a period of time, to satisfy both the fluidic and electrode constraints. Therefore, the droplet-transportation time is potentially increased. In this section, we detail how to determine the droplet-movement cost.
The droplet-movement cost w i j (x, y) when a droplet d i j moves to cell (x, y) consists of routing and congestion costs and is defined as follows:
where r Note that one special case for routing cost computation is that another droplet d 
where d m (x, y, x , y ) is the Manhattan distance between cells (x, y) and (x , y ). The congestion information is updated at every time step for the latest congestion information.
To obtain more accurate congestion information, it is not sufficient to only consider the congestion information of the possible destination cell (x, y). In this paper, we consider the congestion information of all cells within the bounding box defined by cell (x, y) and its sink. Note that we use the real bounding box computed by the A * -search algorithm. For example, as shown in Fig. 7 , when computing the congestion cost of cell c 1 , we consider all cells within the dashed region, which represents the real bounding box. Therefore, the congestion cost g 
If the congestion cost is large, it is likely that the electrode and fluidic constraints will be violated if d i j moves to cell (x, y). Therefore, the proposed routing algorithm will not tend to move a droplet to cell (x, y).
D. Handling Three-Pin Nets
For a three-pin net n i , the two droplets must be mixed during their transportation. To guarantee that these two droplets are mixed, first, these two droplets route toward each other. After they merged, we consider them as one droplet and route them toward their sink. Therefore, for droplet-movement-cost computation, the sink of d 
E. Complexity Analysis
For each droplet, five variables are used to represent its position at next time step, and five variables are used to capture cell activation. The number of variables for row/column-voltage assignment is O(ŴĤ). Therefore, the total number of variables for the progressive-ILP formulation is O(|D| +ŴĤ).
There are a total of O(ŴĤ) constraints for row/columnvoltage assignment. It is easy to see that the number of other constraints is proportional to the number of droplets. Therefore, the number of constraint in the progressive-ILP formulation is O(|D| +ŴĤ).
Based on the earlier analysis, we have the following observation: Given a set of droplets D and a biochip of the width (height)Ŵ (Ĥ), the number of variables and constraints of the progressive-ILP formulation for one problem instance (one time step) are O(|D| +ŴĤ) and O(|D| +ŴĤ), respectively.
F. Implementational Issues
We now present several implementation details associated with obtaining a fast and reasonable solution to this problem. To further reduce the problem size, we add a restriction that a . We can also eliminate the electrode constraint for these cells. Finally, the voltage assignment and cell-activation constraint is replaced by the following two constraints to ensure that this cell is not activated:
V. SIMULATION RESULTS Our progressive-ILP algorithm was implemented in the C++ language, and GLPK [15] is used as our ILP solver. For purposes of comparison, we have also implemented the cliquepartitioning-based [11] and the graph-coloring-based [8] algorithms. All of the above algorithms and ILP formulations are executed on a 1.2-GHz SUN Blade-2000 machine with 8-GB memory. We evaluated our routing algorithm on the two practical bioassays: the in vitro diagnostics [9] and the colorimetric protein assay [16] . Table II shows the statistics of each benchmark [10] : column two shows the chip dimension, column three lists the total number of 2-D planes, and column four lists the total number of nets of all 2-D planes.
We performed two experiments to verify the efficiency and effectiveness of the progressive-ILP algorithm. In the first experiment, we compared the basic ILP with the reduction method presented in Section III-C and progressive-ILP algorithms. We generated both the basic and progressive-ILP formulations for each 2-D plane. The simulation results are listed in Table III . Columns two and three (columns four and five) list the maximum number of variables (constraints) of all problem instances. For the basic ILP, the problem instance is one 2-D plane, and for TABLE IV  COMPARISON BETWEEN OUR APPROACH AND TWO METHODS BASED ON MAPPING DIRECT-ADDRESSING SOLUTIONS the progressive-ILP, the problem instance is one time step. The results show that the basic ILP requires at least five days to solve all 2-D planes of one benchmark, which is not feasible for this problem; in contrast, the proposed progressive-ILP algorithm requires at most 15.36 s due to the significantly smaller problem size. For example, as shown in Table III , for the protein_1 benchmark, the progressive-ILP routing scheme can reduce the number of variables (constraints) by 99.72% (99.89%) for the largest problem instance. This result demonstrates the efficiency of the progressive-ILP formulation.
The proposed progressive-ILP formulation can obtain a nearoptimal solution with much less CPU time as compared with the basic ILP formulation. For example, for one 2-D plane of the protein_1 benchmark with four droplets, the progressive-ILP formulation obtains a solution of 21 cycles in 0.40 s while the basic ILP formulation obtains a 20-cycle solution in 19 632 s. Since it is not feasible to solve the basic ILP for practical bioassays, it is not possible to compare the solution quality of these two algorithms directly. Nevertheless, it is observed that the difference in the solution quality for the two algorithms is at most three cycles for 41 2-D planes completed by the basic ILP formulation, and the average solution difference is only 1.68%. The result indicates that the progressive-ILP algorithm is close to the optimal solution.
In the second experiment, we verified the quality of the proposed progressive-ILP routing scheme. Since previous works require a direct-addressing routing solution for a fair comparison, we first generated the direct-addressing routing solution using the network-flow-based algorithm [10] and applied the previous approaches to obtain the final routing solution. Moreover, we modified the network-flow-based algorithm to minimize the droplet-transportation time. Table IV shows the simulation result. We report the maximum and average T l of all 2-D planes and the CPU time to route all 2-D planes. The CPU times for [10] + [11] and [10] + [8] are the total CPU times to obtain the cross-referencing routing solution. As shown in this table, the progressive-ILP routing algorithm can obtain much smaller droplet-transportation times (in cycles) than the previous approaches, under reasonable CPU times. demonstrates that the proposed algorithm is very effective for droplet routing on cross-referencing biochips. Fig. 8 shows the routing result of one 2-D plane of the diagnostics_1 benchmark at cycle eight.
There are two reasons why the progressive-ILP-based routing algorithm can obtain an improved solution as compared with previous works. The first is that our algorithms directly target droplet routing on cross-referencing biochips without going through the intermediate step of finding a solution that is optimal for direct-addressing routing. Therefore, this method has more flexibility than previous works in exploring the solution space. The second is that the proposed algorithm maximizes the number of droplet movements at each cycle by using the real routing distance as part of droplet-movement cost. To minimize cost, droplets tend to move to their sinks at each cycle. Moreover, our algorithm incorporates a probabilitybased congestion cost that avoid droplets to move to congested regions and, therefore, avoids additional detours or stalls that increase droplet-transportation time. In contrast, both [8] and [11] require a direct-addressing routing solution, and they are less flexible than our algorithm. Moreover, the technique proposed in [11] iteratively moves a set of droplets whose destination cells are in the same row/column. However, droplets whose destination cells are not in the same row/column can still move at the same time as long as they do not violate electrode constraint. Therefore, their algorithm may lose the optimality of minimizing droplet-transportation time.
Another difference is that the graph-coloring-based algorithm [8] assumes that four cells are activated when two droplets move at the same time. However, by properly assigning high/low voltages to each row/column, only two instead of four cells activate. For example, as shown in Fig. 2 , the two extra cells can be eliminated by assigning high voltage to the row containing droplet three and low voltage to the column where two extra activated cells are originally at. In other words, the algorithm in [8] does not exploit the ability of a biochip to assign voltages to each row/column to maximize the number of droplets movement at the same time.
VI. CONCLUSION
In this paper, we have proposed the first droplet routing algorithm that operates directly on cross-referencing biochips without a direct-addressing routing solution. We have also presented the basic ILP formulation to minimize the droplettransportation time and the progressive-ILP routing scheme to iteratively determine the minimum-cost positions of the droplets at each time step. Simulation results have shown the efficiency and effectiveness of our algorithm.
The target biochip can be viewed as a passive-matrixaddressing biochip, since we must activate a row/column to activate a cell. There are other types of biochips that use active matrix addressing [17] . Each electrode has its unique addressing; therefore, we can uniquely activate an electrode without introducing the electrode-interference problem. However, the hardware and package costs may increase due to the extra control circuitry. We are currently trying to apply our droplet routing algorithm to these types of biochips.
